-Most big pharma companies do very little basic R&D; Novo just happens to be one of the few
-GLP-1s were discovered for their diabetic therapeutic effects. The appetite suppression was chancy especially since the mechanism is different than the insulin effects
-Most big pharma companies do very little basic R&D; Novo just happens to be one of the few
-GLP-1s were discovered for their diabetic therapeutic effects. The appetite suppression was chancy especially since the mechanism is different than the insulin effects
-Although this article isn’t wrong that the market size was uncertain, I don’t think it took a genius to say “if you had a drug that made people thin you’d be very rich”
Could it just be luck? Consider:
-Most big pharma companies do very little basic R&D; Novo just happens to be one of the few
-GLP-1s were discovered for their diabetic therapeutic effects. The appetite suppression was chancy especially since the mechanism is different than the insulin effects
-Although this article isn’t wrong that the market size was uncertain, I don’t think it took a genius to say “if you had a drug that made people thin you’d be very rich”